Details of the Drug Reposition

General Information of This Drug (ID: DMCIY7N)

Drug Name
CRL-8131   DMCIY7N
Synonyms Flocor; RheothRx; Poloxamer 331; ANX-188; CRL-5861; P-188; Poloxamer-188; RheothRx-pf
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
3 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Bacterial infection DIS5QJ9S 1A00-1C4Z Phase 3 [1]
Non-small-cell lung cancer DIS5Y6R9 2C25.Y Phase 3 [2]
Sickle-cell disorder DISW25G5 3A51 Phase 3 [3]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT00004408) Phase III Randomized Study of Poloxamer 188 for Vaso-Occlusive Crisis of Sickle Cell Disease. U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT01737814) Evaluation of Purified Poloxamer 188 in Vaso-Occlusive Crisis of Sickle Cell Disease (EPIC). U.S. National Institutes of Health.
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)